NAVB
Navidea Biopharmaceuticals Inc.
NAVB
NAVB
Delisted
NAVB was delisted on the 5th of October, 2023.
25 hedge funds and large institutions have $383K invested in Navidea Biopharmaceuticals Inc. in 2022 Q3 according to their latest regulatory filings, with 3 funds opening new positions, 5 increasing their positions, 4 reducing their positions, and 4 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less funds holding
Funds holding: →
less first-time investments, than exits
New positions opened: | Existing positions closed:
less capital invested
Capital invested by funds: $ → $
73% less call options, than puts
Call options by funds: $14K | Put options by funds: $52K
Holders
25
Holding in Top 10
–
Calls
$14K
Puts
$52K
Top Buyers
| 1 | +$10K | |
| 2 | +$10K | |
| 3 | +$3.58K | |
| 4 |
Hudson Bay Capital Management
Stamford,
Connecticut
|
+$3K |
| 5 |
PFO
Pathstone Family Office
Englewood,
New Jersey
|
+$2.77K |
Top Sellers
| 1 | -$17K | |
| 2 | -$10K | |
| 3 | -$9.23K | |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
-$6.04K |
| 5 |
Simplex Trading
Chicago,
Illinois
|
-$2.23K |